BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim J, Jang S, Choi M, Chung S, Choe Y, Choe HK, Son GH, Rhee K, Kim K. Abrogation of the Circadian Nuclear Receptor REV-ERBα Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration. Mol Cells 2018;41:742-52. [PMID: 30078232 DOI: 10.14348/molcells.2018.0201] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
Number Citing Articles
1 Kou L, Chi X, Sun Y, Han C, Wan F, Hu J, Yin S, Wu J, Li Y, Zhou Q, Zou W, Xiong N, Huang J, Xia Y, Wang T. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome. J Neuroinflammation 2022;19:133. [PMID: 35668454 DOI: 10.1186/s12974-022-02494-y] [Reference Citation Analysis]
2 Kim J, Park I, Jang S, Choi M, Kim D, Sun W, Choe Y, Choi JW, Moon C, Park SH, Choe HK, Kim K. Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson's Disease. Neurotherapeutics 2022. [PMID: 35322351 DOI: 10.1007/s13311-022-01215-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hunt J, Coulson EJ, Rajnarayanan R, Oster H, Videnovic A, Rawashdeh O. Sleep and circadian rhythms in Parkinson's disease and preclinical models. Mol Neurodegener 2022;17:2. [PMID: 35000606 DOI: 10.1186/s13024-021-00504-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Liu Y, Niu L, Liu X, Cheng C, Le W. Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation. Neurosci Bull 2021;37:1010-24. [PMID: 34128188 DOI: 10.1007/s12264-021-00711-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
5 Kim K, Kim JH, Kim I, Seong S, Kim N. Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway. Mol Cells 2020;43:34-47. [PMID: 31896234 DOI: 10.14348/molcells.2019.0232] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
6 Yue J, He J, Wei Y, Shen K, Wu K, Yang X, Liu S, Zhang C, Yang H. Decreased expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and neuroprotective effects in the pilocarpine model. J Neuroinflammation 2020;17:43. [PMID: 32005256 DOI: 10.1186/s12974-020-1718-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
7 Cha HK, Chung S, Lim HY, Jung JW, Son GH. Small Molecule Modulators of the Circadian Molecular Clock With Implications for Neuropsychiatric Diseases. Front Mol Neurosci 2018;11:496. [PMID: 30718998 DOI: 10.3389/fnmol.2018.00496] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
8 De Lazzari F, Bisaglia M, Zordan MA, Sandrelli F. Circadian Rhythm Abnormalities in Parkinson's Disease from Humans to Flies and Back. Int J Mol Sci 2018;19:E3911. [PMID: 30563246 DOI: 10.3390/ijms19123911] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]